SYSTEMATIC LITERATURE REVIEW FOR TREATMENT OUTCOMES (INCLUDING IMMUNO-ONCOLOGY TREATMENT) AMONG PATIENTS WITH STAGE 3 UNRESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC)

被引：1
|
作者：
Zhou, Z. [1 ]
Song, J. [2 ]
Ouwens, M. J. [3 ]
Huhn, M. [3 ]
Jiang, H. [4 ]
Zhang, Y. [4 ]
Dalevi, D. [3 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Anal Grp Inc, Los Angeles, CA USA
[3] Astrazeneca, Molndal, Sweden
[4] Astrazeneca, Gaithersburg, MD USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.110
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN28
引用
收藏
页码：A416 / A416
页数：1
相关论文
共 50 条
  • [41] REAL-WORLD TREATMENT PATTERNS IN RESECTABLE (STAGE I-IIIA) NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW (SLR)
    Waser, N.
    Vo, L.
    McKenna, M.
    Kaushik, N.
    Penrod, J. R.
    Breckenridge, M.
    Goring, S.
    [J]. VALUE IN HEALTH, 2020, 23 : S24 - S24
  • [42] Does more aggressive therapy improve outcomes in the treatment of unresectable stage III non-small cell lung cancer?
    Rosenman, JG
    Socinski, MA
    [J]. SEMINARS IN ONCOLOGY, 2005, 32 (02) : S13 - S17
  • [43] Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment
    Alduais, Yaser
    Zhang, Haijun
    Fan, Fan
    Chen, Jing
    Chen, Baoan
    [J]. MEDICINE, 2023, 102 (08) : E32899
  • [44] Non-surgical multimodality treatment of stage III non-small cell lung cancer (NSCLC)
    De Ruysscher, D.
    [J]. LUNG CANCER, 2006, 52 : S1 - S1
  • [45] Non-surgical multimodality treatment of stage III non-small cell lung cancer (NSCLC)
    De Ruysscher, D.
    [J]. Proceedings of the 10th Central European Lung Cancer Conference, 2006, : 1 - 4
  • [46] Is the Importance of Heart Dose Overstated in the Treatment of Non-Small Cell Lung Cancer? A Systematic Review of the Literature
    Zhang, Tina Wanting
    Snir, Jonatan
    Boldt, R. Gabriel
    Rodrigues, George B.
    Louie, Alexander V.
    Gaede, Stewart
    McGarry, Ronald C.
    Urbanic, James J.
    Daly, Megan E.
    Palma, David A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (03): : 582 - 589
  • [47] Curative Treatment Rates for Patients Diagnosed with Early Stage Non-Small Cell Lung Cancer (NSCLC) in England
    Khakwani, A.
    Harden, S.
    Baldwin, D.
    Foweraker, K.
    Navani, N.
    Dickinson, R.
    West, D.
    Beckett, P.
    Hubbard, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1980 - S1980
  • [48] Treatment Initiation, Tolerance and Survival in Elderly Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC)
    Helfrich, G.
    Gijtenbeek, R. G.
    Venmans, B. J.
    Ten Brinke, A.
    De Jong, K.
    van Geffen, W. H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] Stage and treatment migration in patients with stage III non-small cell lung cancer
    Hubbs, J. L.
    Fatunase, T.
    Hollis, D. R.
    Clough, R. W.
    Kelsey, C. R.
    D'Amico, T. A.
    Marks, L. B.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S159 - S160
  • [50] CLINICAL CHARACTERISTICS AND TREATMENT PATTERNS OF PATIENTS WITH EARLY-STAGE NON-SMALL CELL LUNG CANCER (NSCLC)
    Flores-Caballero, M. A.
    Lugo-Martinez, G.
    Rodriguez-Cid, J. R.
    Juarez-Vignon Whaley, J.
    Cruz-Zermeno, M.
    Seidman-Sorsby, A.
    Martinez-Herrera, F.
    Garcia-Montes, V
    Garibay-Diaz, J. C.
    Espinosa, Gonzalez, I
    Hernandez-Flores, O.
    Oyervides-Juarez, V. M.
    Gonzalez-Cisneros, P.
    Sala, Riera R.
    Alatorre-Alexander, J.
    Betancur, M. A.
    Medina, S.
    Rojowska, A.
    Lopez Lopez, F.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S217 - S217
12345